CJRS-10671 and CJRS-10672, biotherapeutic candidates with promising antitumor efficacy in vivo April 25, 2022
CLN-978, a next-generation CD19-targeted therapeutic for the treatment of B-cell malignancies April 25, 2022
EGFR-TKI TAS-3351 overcomes T790M and C797S mutations tied to NSCLC treatment resistance April 25, 2022
n-Lorem receives funding to support ASO discovery for nano-rare neurodevelopmental diseases April 22, 2022
RSS